• Company
    • Corporate Profile
    • Management Team
    • Directors
    • Ophthalmic Advisory Board
    • Urology Advisory Board
    • Wound Care Advisory Board
    • Careers
  • Partners
    • Partnership Strategy
    • Galderma
    • Pioneer Pharma
    • Virbac
    • IHT
    • Partnership Opportunities
  • Clinical Trials
    • BAYnovation
    • UROvation
  • Technology
    • Overview
    • Aganocides
    • Pipeline
    • Biofilm
    • Antibiotic Resistance
    • NovaBay Publications
    • Relevant Articles
  • Investors
    • Shareholder Information
    • Press Releases
    • Events
    • Stock Information
    • Regulatory Filings
    • Corporate Governance
    • Corporate Presentation
  • News & Events
  • Media
  • Contact
  • display-pinkeye
  • neutrophase-skin-and-wound-cleanser-homepage
  • display-ucbe
  • display-impetigo

Press Releases

June 17, 2013

NovaBay Supports Legislation to Attack Antibiotic Resistance

June 11, 2013

NovaBay Pharmaceuticals Mid-Year Clinical Update

All Press Releases

CEO Blog

Ramin ("Ron") Najafi is the founder and Chairman of NovaBay. He has served as President since July 2002, and as Chief Executive Officer since November 2004.

Annual Report

2012 Annual Report: Going Beyond Antibiotics

© Copyright 2007 - 2013 NovaBay Pharmaceuticals, Inc. All Rights Reserved. Various trademarks held by their respective owners.

NovaBay Pharmaceuticals, Inc.
    • Home
    • Legal Disclaimer
    • Site Map